Drug "Pradaksa". Ntuziaka maka ojiji

Ọgwụ "Pradaksa" bụ anticoagulant, a kpọmkwem thrombin inhibitor. Absorption ego bụ ngwa ngwa. The kacha ọdịnaya nke ọgwụ esịmde na nso nke 30-120 nkeji. The nri na bioavailability nke ọgwụ nwere dịghị mmetụta. Ewepụtara ọgwụ na-agbanweghi agbanwe ụdị, isi site na akụrụ ya.

na-agba akaebe

Pụtara "Pradaksa" ntuziaka maka ojiji na-atụ aro maka mgbochi nke thromboembolism na ọrịa n'ịnwụ orthopedic n'ịwa ahụ.

dosing Usoro

The ọgwụ na-owụt maka onu ochichi. The onunu ogwu maka prophylactic nzube bụ 220 mg / ụbọchị. The ọgwụ ẹka ozugbo. Na-anaghị ekwe nke na-agafeghị oke eruba nke gbasara akụrụ ọrụ na elu n'ihe ize ndụ nke ọbara ọgbụgba. Na nke a, na ọ na-atụ aro iji belata onunu ogwu 150 mg / ụbọchị. Mgbe ngụkọta ikpere nkwonkwo iji gbochie venous thromboembolism ewere ọgwụ "Pradaksa" ntụziaka ntuziaka na-atụ aro na-amalite mgbe otu anọ awa mgbe aka. The mbụ dose na 110 mg nke a jiri nwayọọ nwayọọ na-abawanye na 220 mg / ụbọchị. Course oge nke 28-35 ụbọchị. Ọ bụrụ na bụghị enweta hemostasis, ọgwụgwọ a ga-egbu oge. Agadi ọrịa (afọ 75) na-atụ aro ka ọ họpụta 150 mg / ụbọchị.

Drug "Pradaksa". Ntuziaka maka ojiji. mmetụta

Na ndabere nke likelihood nke na-agba ọbara ọgwụ dị iche iche orunótu. The agwọ ọrịa nwere ike ime ka thrombocytopenia, hematuria, hemarthrosis, anaemia, hemorrhagic syndrome. Na ụfọdụ ndị ọrịa e nwere a aghara nke hepatic ọrụ, mụbara ọrụ nke ya enzymes. The mmetụta ọjọọ na-agụnye a ọnụ ke haemoglobin, hematomas mgbe usoro, ntoputa nke ọbara n'ahụ si ọnya.

"Pradaksa" n'aka. Ntuziaka maka ojiji. contraindications

The ọgwụ na-adịghị akwadoro maka oké gbasara akụrụ odida, hemorrhagic ọrịa (gụnyere diathesis). Medicine "Pradaksa" (Ibọrọ ndị ọkachamara gosi na nke a) na-adịghị gosiri maka ifịk clinically ịrịba ọbara ọgbụgba na ọnya na akụkụ dị ka a N'ihi nke a, hypersensitivity, imeju pathologies na pụrụ imetụta ndụ. Ọ na-atụ aro ọgwụ tupu afọ nke iri na asatọ afọ, hemostasis ọrịa (n'amaghi ama ma ọ pharmacologically rata). Contraindications gụnyere na ime na lactation.

Maka ozi ọzọ,

Mgbe ị na-enweta a elu-dose ọgwụ hụrụ ọbara ọgbụgba. Mgbe ya emee, ọgwụgwọ a ga-kwụsịtụrụ jide nkọwa nke ọdịdị nke onu. Nyere ụzọ na igba egbe ụgbọala (site na akụrụ), mgbe nsí na steeti dị mkpa iji nye diuresis. Mgbe ụfọdụ, i nwere ike mkpa a mịnye nke plasma (ọhụrụ na friji) ma ọ bụ ịwa ahụ hemostasis. Ná nhọpụta nke NSAIDs na njikọ na ọgwụ anaghị ibelata ihe ize ndụ nke ọbara ọgbụgba. Na omume nke nnukwu gbasara akụrụ odida mgbaàmà kwụsị ọgwụ. The mbụ dose of ọgwụ e nweghị tupu awa abụọ mgbe catheter mwepụ. The nkwadebe na-echekwara n'ebe ụmụ. The ngwá ọrụ na ndenye ọgwụ.